AbbVie (ABBV): The Best Stock to Buy on a Pullback

AbbVie Inc. (NYSE:ABBV) is one of the 10 Stocks to Buy on a Pullback.

On April 20, 2026, Canaccord initiated coverage of AbbVie Inc. (NYSE:ABBV) with a Buy rating and a $262 price target on the shares, offering an upside potential of around 29% from AbbVie Inc. (NYSE:ABBV)’s last close.

On April 12, 2026, CollPlant disclosed that Allergan Industrie SAS, an AbbVie company, exercised its right to terminate a development agreement originally signed in February 2021, with termination taking effect after a 60-day notice period. The partnership had focused on developing dermal and soft tissue fillers using CollPlant’s rhCollagen technology for the medical aesthetics market. Despite the termination, CollPlant indicated it continues to see strong interest in its collagen platform and is actively pursuing new partnerships, including discussions with multiple strategic and Tier 1 companies for potential collaborations in aesthetic applications.

AbbVie (ABBV): The Best Stock to Buy on a Pullback

Pixabay/Public domain

A day earlier, AbbVie Inc. (NYSE:ABBV) announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented at the 2026 Society of Gynecologic Oncology Annual Meeting. The study evaluated mirvetuximab soravtansine-gynx (Elahere) in combination with carboplatin, followed by monotherapy maintenance, in patients with folate receptor alpha-positive, platinum-sensitive ovarian cancer. The trial enrolled 125 patients and focused on objective response rate as the primary endpoint, with additional measures including duration of response, progression-free survival, and overall survival.

AbbVie Inc. (NYSE:ABBV) develops and markets pharmaceutical therapies across multiple therapeutic areas globally.

While we acknowledge the risk and potential of ABBV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ABBV and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.